Delivery Order SPE2DB24D2205-SPE2DB25FDXMN

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $9.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $9,335.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,931,170 units of the drug Clobazam 10 mg Tablet in 100-count packages. The contract has a period of performance through January 15, 2025 and does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,667.79 firm fixed-price delivery order is for the supply of 4,567,039,867 units of the drug Clobazam 10 mg tablets. The contract has an ultimate completion date of January 27, 2025 and was awarded on January 24, 2025. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $3,693.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,135,426 units of the medication clobazam 10 mg tablets. The award has an ultimate completion date of October 18, 2024 and is structured as a firm-fixed-price delivery order. No set-aside designation was used for this contract. Amerisourcebergen holds a...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,565,176,880 units of the drug clobazam 10 mg tablets. The $1,555.93 firm fixed price contract has a completion date of July 18, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, valued at $3,111.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,316,903 units of the prescription drug clobazam 10 mg tablet in 100-count bottles. The contract has a period of performance through February 20, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,667.79 firm-fixed-price delivery order is for the supply of 4,566,760,154 units of the medication clobazam 10 mg tablets. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,053.33 firm fixed-price delivery order is for the supply of 4,567,363,282 units of the pharmaceutical drug Clobazam 10 mg tablets. The contract has an ultimate completion date of February 25, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
The federal contract award detailed here was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,325.36 fixed-price delivery order is for the supply of 4,567,445,189 units of the drug clobazam 10 mg tablets. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,296.60 firm fixed-price delivery order is for the supply of 4,566,848,140 units of the prescription drug clobazam 10 mg tablets. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,555.93 firm fixed-price delivery order is for the supply of 4,567,154,080 units of Clobazam 10 mg tablets. The award has an ultimate completion date of February 5, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDXMN
    Delivery Order

This federal contract award of $9,728.52 was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,567,074,533 units of the drug Clobazam 10 mg tablets in 100-count bottles. The contract has an ultimate completion date of January 29, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/29/25, 10:02 AM